What's on Practical Law?

Upheaval in the insurance industry: potential implications for policyholders

Practical Law UK Articles 2-200-4590 (Approx. 10 pages)

Upheaval in the insurance industry: potential implications for policyholders

by John Magnin, Neal Brendel and Roberta Anderson, Kirkpatrick & Lockhart Nicholson Graham LLP
Recent investigations in the US into the insurance industry, and particularly the business practices of insurance brokers, carry potentially significant implications for corporate policyholders around the world. This article summarises the recent investigations, reviews the relevant law governing insurance brokers in the UK and the US, and provides some practical guidance for companies that may have been affected by the business practices in issue.
On 14 October 2004, Eliot Spitzer, the Attorney General of the State of New York, filed a complaint against the world’s largest insurance broker, Marsh Inc, and its parent, Marsh & McLennan Companies, Inc (Marsh). The complaint alleged that Marsh harmed corporate policyholders by, among other things, collecting large payments from favoured insurers as rewards for steering business to those insurers.
Spitzer’s complaint made reference to some of the insurance industry’s most prominent global players in addition to Marsh, including American International Group Inc (AIG), ACE Ltd and Hartford Financial Services Group Inc (Hartford). Although the complaint was brought against Marsh alone, many of the industry’s most prominent brokers, and more than a dozen insurers, received subpoenas from Spitzer’s office, as well as requests from other state prosecutors and regulators, seeking information regarding their business practices.
The complaint and related investigations have reverberated through the insurance industry, which is dominated by a small group of companies and is essentially global in nature. In its wake, EU officials are reportedly considering launching a probe into insurance brokerage, targeting similar areas to those spotlighted by Spitzer. And in the UK, while the Financial Services Authority (FSA) has so far resisted undertaking an investigation, it is said to be monitoring the ongoing investigations in the US and keeping a close eye on the UK market.
These developments have the potential to significantly impact on the insurance policies that companies have in place and on the industry in general. As a result, this article:
  • Briefly outlines the scope and nature of the Spitzer investigation.
  • Provides an overview of current law in the UK and the US governing the relationship between insurance brokers and their clients, and lists some remedies potentially available to corporate policyholders if a breach of that law takes place.
  • Considers the ongoing commercial impact of the Spitzer investigation.
  • Offers some practical considerations for companies that may have been affected by the type of wrongful practices alleged in the complaint against Marsh and for dealings with their insurance brokers and other intermediaries going forward (see box, Practical considerations for policyholders).

Scope and nature of investigation

The allegations in Spitzer's complaint, and related allegations, arose out of a series of investigations commenced in Spring 2004. The initial targets of the investigations included, in addition to Marsh, the second largest brokerage organisation in the US, Aon Corp of Chicago, and Willis Group Holdings, Inc.
Spitzer’s 87-paragraph, six-count complaint against Marsh alleged that the broker:
  • Engaged in bid-rigging, by allegedly soliciting or fabricating sham and inflated bids from some insurance companies to ensure that a favoured insurer’s bid would win a particular piece of business; and
  • Orchestrated an elaborate price-fixing scheme in the insurance industry, by allegedly using the practice of accepting contingent commissions from insurance companies (see box, What are contingent commissions?), as vehicles for kickbacks to steer business to favoured insurers, including AIG, ACE Ltd and Hartford.
Reportedly, Spitzer has been probing arrangements under which Aon steered business to insurers who in turn would let the broker arrange its reinsurance, one of Aon’s specialities (Chicago Tribune, 18 December 2004).
On 30 January 2005, Marsh entered into a settlement with Spitzer and the New York State Insurance Department. Under the historic settlement agreement, Marsh agreed to:
  • Create a US$850 million (about EUR642 million) fund to compensate US policyholder clients that used Marsh Inc. to place coverage beginning between 1 January 2001 and 31 December 2004, on which placements Marsh collected contingent commissions or overrides.
  • Undertake business practices reforms and stop:
    • collecting any form of contingent payments from insurers;
    • bid-rigging arrangements;
    • reinsurance brokerage leveraging; and
    • inappropriate use of wholesalers.
  • Provide clients with comprehensive disclosure of all forms of payments received from insurers.
  • Not to accept a percentage commission on premiums unless, before the binding of any policy:
    • Marsh, in plain, unambiguous written language, fully discloses such commissions, in either dollars or percentage amounts; and
    • the client consents in writing.
  • Issue a public apology for the unlawful and shameful conduct of certain Marsh employees.
(K&LNG Alert, Marsh Settles Spitzer Charges For $850 Million, February 2005.)
Likewise, on 4 March 2005, Aon agreed to pay US$190 million (about EUR142 million) in restitution payments as part of a joint settlement with five agencies (including attorneys general in New York, Connecticut and Illinois) of charges alleging that Aon fraudulently manipulated client insurance placements for its own benefit and linked insurance placements with reinsurance brokerage business (Business Insurance, 7 March 2005). Aon also agreed to revamp its business practices as part of the settlement. Under terms of the settlement, Aon will deposit the US$190 million into a settlement fund that will be distributed to clients based on a formula to be approved by the parties to the litigation.
In addition to brokers, Spitzer’s investigation has probed a number of insurance companies, including Chubb, AIG, ACE Ltd, Hartford and St Paul. Whether charges will be filed against these insurers appears to remain an open issue. Reportedly Spitzer’s office is trying to reach settlements with a number of insurance companies under investigation.
In the meantime, Spitzer’s investigations and inquiries continue to widen (Business Insurance, 10 January 2005):
  • In December 2004, Spitzer announced that he would sue consulting firm Universal Life Resources (ULR), which specialises in life, accident and disability insurance, alleging that the company steered business to insurers in exchange for lucrative payoffs and that this practice raised premiums.
  • Most recently, Berkshire Hathaway Inc said it had received a subpoena from the New York State Attorney General’s office demanding information about its reinsurance subsidiary General Re Corp (Associated Press, 7 January 2005).
  • Spitzer reportedly plans to examine offshore insurance entities (Business Insurance, 10 January 2005) and third-party claims administrators (Post Magazine, 16 December 2004).
In addition, since Spitzer unveiled his complaint against Marsh, more than 25 other US state regulators across the US, including state attorneys general and insurance departments, have begun their own investigations focused on insurance industry payment practices.

English law governing insurance brokers

In England and Wales, insurance brokers are regulated by:
  • The law of agency.
  • The FSA Insurance Conduct of Business Rules (ICOB).
  • The law of contract.

Law of agency

Generally, although the law of agency requires fact-specific enquiry, it is regularly contended that an independent broker is the agent of the customer, his principal, for whom he has been instructed to find insurance. The law of agency provides a relatively well-defined set of rights and remedies for agents and principals alike. The starting point is that agency is a form of fiduciary relationship.
The key obligation of a fiduciary is that of loyalty (Bristol & West v Mothew, [1996] 4 All ER 698). Consistent with this obligation of loyalty, an agent cannot, without his principal’s consent, place himself in a position, or enter into a transaction, in which his personal interest, or his duty to another principal, may conflict with his duty to his principal. The principal’s consent is only valid if he has full knowledge of all the material circumstances and of the nature and extent of the agent’s interest.
The duty of good faith implicit in the relationship between principal and agent means that the agent must act at all times in the interest of the principal and must not let his own interests conflict with those of his principal (see Logicrose v Southend United FC [1988] 1 WLR. 1256). In addition: “The principal is entitled to the disinterested advice of his agent free from the potentially corrupting interest of his own. Any such private interest, whether actual or contemplated, which is not known and consented to by his principal, disqualifies” the agent (Logicrose; see also Keith Henry & Co. Pty Ltd v Stuart Walker & Co. Pty Ltd [1958] 100 CLR 342).
In the context of insurance, there is the obvious potential for a conflict of interest to arise between a broker’s duty to find the most suitable insurance policy in the market, and his interest in obtaining the best commission possible.
To the extent a broker is deemed to be the insured's agent, therefore, it is important to note that, under well-established rules of agency, an agent cannot, without the knowledge of his principal, use his position to acquire for himself a benefit (that is, a secret profit) from a third party, other than that contemplated by the principal at the time of entering into the agency relationship (Halsbury's Laws of England, Agency). The agent must account to his principal for any such unauthorised benefit obtained in breach of these rules (Regier v Campbell-Stuart [1939] 3 All ER 235).

ICOB

From 14 January 2005, the general insurance industry has been subject to a transition from regulation by the General Insurance Standards Council (GISC) to statutory regulation by the FSA.
The FSA has published business conduct rules (ICOB) for insurance intermediaries, the majority of which are in accordance with the GISC’s former regime. Among other things, this new regulation by the FSA, in the form of the ICOB, governs the disclosure of commission for commercial customers (ICOB at 4.6).
Although ICOB does not specifically address contingent commissions it:
  • Stipulates that a firm must “conduct its business with integrity, ... pay due regard to the interests of its customers and ... treat them fairly” (ICOB at §2.3.1).
  • Sets out specific rules relating to unfair inducements.
  • Provides further guidance on the issue of remuneration.
These rules include the clear mandate that a broker must not offer, give, solicit or accept an inducement that is likely to cause a conflict of interest with respect to its duties to the policyholder (ICOB at §2.3.2).
In this regard, the FSA has recently outlined situations where it believes contingent commissions and other inducements represent a conflict of interest. In a letter to insurance market trade associations and the Association of Insurance and Risk Managers, the FSA provided two examples of situations where an inducement would be determined to be a conflict:
  • If an intermediary “holds himself out as getting the best deal for his customers, and the inducement influences his placement of business in a way that is contrary to his customers’ interests.”
  • If an intermediary “is involved in settlement of claims and also receives a profit commission that influences how he settles claims on behalf of his customers in a way that is contrary to his customers’ interests.”
(Business Insurance, 1 February 2005.)
In addition, the rules require that brokers have an internal procedure in place to determine whether inducements are in violation of the rules: “For example, it should be able to identify situations where the existence of an inducement has caused a course of action to be adopted, that conflicts to a material extent with any duty that the firm owes to its customers, and which would not have been taken in the absence of the inducement. It should also have in place a mechanism for remedying such situations should they occur” (ICOB at §2.3.9).
Finally, ICOB requires that, if requested by the policyholder, a broker “must promptly disclose the commission that he receives” (ICOB at §4.6.2) and, more broadly, requires that a broker must, regardless of whether information is requested, “provide a commercial customer with sufficient information to enable the commercial customer to make an informed decision about the contract being proposed [and] the premium and any fees relating to the [contract]” (ICOB at §5.4.1).
At a minimum, the FSA will require brokers, on request from a policyholder, to disclose commission in cash terms, or to the extent it cannot be indicated in cash terms, the basis of calculation of the commission. The level of detail must be sufficient to enable the customer to verify the amount. This must include all forms of remuneration including profit share, volume overriders and payments from premium finance companies.
Breach of ICOB can, in some circumstances, give rise to a claim for damages under section 150 of the Financial Services and Markets Act 2000 or disciplinary action by the FSA (or both).

Contract and other possible claims

If an insurance intermediary has not complied with his obligations, either express or implied, in the terms and conditions of a contract, his client could sue him for breach of contract, the remedy being damages. A broker’s terms of retainer may impose an express obligation on the broker to disclose all commissions received from the insurer. If this obligation has not been properly complied with, a policyholder may be able to bring an action for breach of contract for losses suffered.
The policyholder may be able to join the insurer into court action if it can be shown that there was an element of conspiracy between the broker and the insurer, that is, if it can be proven that the insurer knew the broker was unlawfully failing to disclose to the policyholder all commissions received. Once again, the remedy will be damages.

US law governing insurance brokers

In the US, each individual state regulates the insurance brokers and other insurance intermediaries that sell, solicit or negotiate insurance in that state. The laws in the majority of states are based on, or are similar to, the Producer Licensing Model Law adopted by the National Association of Insurance Commissioners (NAIC), a voluntary association of the state insurance regulators for all US states.
In response to allegations of misconduct and violations of existing insurance laws by brokers and insurers, the NAIC formed an Executive Task Force on Broker Activities on 1 November 2004. The purpose of the task force is, among other things, to develop a model act for brokers’ disclosure of compensation.
On 29 December 2004, the Task Force adopted a “Compensation Disclosure Amendment to the Producer Licensing Model Law”. Under this Amendment, if a retail broker receives any compensation from an insurer, the broker would be required to do both of the following before the customer buys insurance:
  • Obtain “the customer’s documented acknowledgement that the compensation will be received” by the broker.
  • Disclose “the amount of compensation [broadly defined to include commissions, overrides and contingent commissions] from the insurer or other third party for that placement”.
The Amendment does not have the force of law until it is enacted into law in a given state. This process is expected to commence shortly.
Under US law, if an insurance broker breaches his duties to his client, a variety of US common law and statutory causes of action may potentially be available, including causes of action for or relating to: unfair and deceptive trade practices, fraud, breach of contract, professional malpractice, professional negligence, breach of the duty to disclose, breach of the covenants of good faith and fair dealing, civil conspiracy, civil action brought under the Racketeer Influenced and Corrupt Organizations Act (18 USC §1961 - 1968) (RICO) and unjust enrichment.

Remedies

Potentially available damages include rescission of the broker engagement and disgorgement of commissions, restitution, compensatory damages (trebled in some instances), punitive damages, attorneys’ fees and costs.
Well-known class action plaintiffs’ counsel, Milberg Weiss and Lerach Coughlin, have filed actions against Aon, Marsh, AIG, ACE Ltd and Hartford. Shareholder plaintiffs allege that:
  • They incurred significant stock losses when the illegal agreements and kickbacks came to light and contend that the insurer defendants violated the anti-fraud provisions of federal securities laws by failing to disclose the illegal kickbacks and by providing Marsh with rigged quotes.
  • The illegal activity violated the insurers’ fiduciary duty to their shareholders, and resulted in the reporting of inflated revenue and income to the investing public.
  • The conduct exposed the companies to both civil and criminal penalties that could hurt the value of the holdings.
United Policyholders, a US consumer organisation, has filed separate actions against Marsh, Aon, and Willis in California, as well as a class action complaint in the Southern District of New York alleging breach of contract, breach of fiduciary duty, negligent misrepresentation, and civil RICO.

Commercial impact

The Spitzer investigation is already impacting on the way that insurance brokers and insurance companies do business. Ultimately, it is expected to have a positive effect on competition in the market.

Business practices

In the past, broker remuneration has not always been adequately disclosed to policyholders. While policyholders might have been aware of the retail commissions they paid and the overall cost of an insurance placement, they were not always aware of other types of commissions their brokers collected (such as wholesale commissions, facultative reinsurance commissions connected with the original insurance placement, and contingent or volume-based override commissions, which refer to the practice of accepting contingent commissions from insurers based, not on the underwriting profitability of the insurer's book of business, but on the volume of business the broker was directing to the insurer).
Spitzer’s investigation has already had a significant impact on the way insurance brokers and insurance companies are conducting business. A number of US brokers, including Marsh and several of its largest competitors, have promised to make their remuneration more “transparent” to clients. In Marsh’s case, for example, this will mean giving clients in the US full disclosure of retail and wholesale commissions, premium finance compensation and other fees charged on their accounts (Business Insurance, 15 November 2004).
As the market, especially corporate policyholders on both sides of the Atlantic, presses for greater transparency and disclosure of monies received by brokers placing their insurance business, it is likely that other insurance brokers in Europe will follow this lead. Indeed, some brokers in the UK, including leading reinsurance brokers, have committed to financial transparency, including full disclosure of contingent commissions (Financial Times, 23 October 2004; Lloyd's List, 17 December 2004).
At a minimum, disclosure by brokers of their total compensation package almost certainly will be required going forward.

Competition

Ultimately, the burgeoning investigation into broker compensation practices will change relationships among risk managers, brokers and insurers, and the possible elimination or limiting of contingent commissions (see box, What are contingent commissions?) may benefit smaller brokers who have not in the past been able to compete with volume placements (National Underwriter, 6 December 2004; Business Insurance, 15 November 2004). Although the world’s largest brokers have long exercised their market power in the global brokering business, the curtailment of contingent commissions may create more competition in the marketplace. In addition, independent insurance consultants may gain increased influence and a greater role in the market overseeing the placement process and providing truly independent advice.
John Magnin and Neal Brendel are partners and Roberta Anderson is an associate in the Insurance Coverage practice group of Kirkpatrick & Lockhart Nicholson Graham LLP. The views expressed in this article are those of the authors and not necessarily those of the law firm or its clients.

What are contingent commissions?

Contingent commissions, also known as placement service agreements (PSAs) or market service agreements (MSAs), are widespread within the global insurance industry, including in the UK and in the US. They are, in effect, bonuses awarded to brokers by insurers for selling high volumes of insurance or more profitable insurance products. At a minimum these entail potential conflicts of interest between brokers and their policyholder clients, as they may incentivise the broker to place insurance based on the best available bonus commission for the broker, as opposed to the best available insurance product for the policyholder.
In addition, such contingent commissions historically have not been adequately disclosed to policyholders. Particularly in the absence of adequate disclosure, a policyholder cannot meaningfully evaluate a broker’s services and may mistakenly take for granted that its broker is acting in the policyholder’s best interests in the placement of insurance and presentation of claims under the policy, as opposed to acting in the broker’s (and insurer’s) financial best interests.
Indeed, the problems of conflicts created by contingent commission arrangements are all the more acute if, as often appears to be the case, the policyholder has no knowledge of the commission being paid to the broker by the insurer.
Another issue arising out of contingent commission arrangements surrounds claim payments. A potential conflict of interest may arise as a broker’s pursuit of insurance claims on behalf of clients may result in the loss of contingent commissions. As a result, a broker may consider the interests of favoured insurance companies over policyholders (as alleged in Spitzer’s complaint against Marsh).
In the context of the ongoing Spitzer investigation, in the weeks immediately following Spitzer’s complaint against Marsh, most of the major US insurance brokers promised to stop accepting contingent commissions entirely. Likewise, although no charges have been brought against them, a number of UK brokers appear to be following suit, while various insurers are understood to be reviewing their practices.
One major issue going forward is how brokers will make up for revenues lost due to the possible abolition of contingent agreements. Brokers may, for instance:
  • Raise upfront commissions.
  • Charge insurers for practices that were previously not invoiced.
  • Raise fees.
  • Cut staff to increase efficiency.
  • Reduce services to maintain profits.

Practical considerations for policyholders

In the light of recent developments, corporate policyholders may wish to consider reviewing:
  • Their current and prior insurance placements.
  • Practice and procedure concerning the engagement of insurance brokers going forward.

Current and prior policies

Mindful of the importance of the business relationship between a policyholder and its insurance broker, which in many instances is long-standing, corporate policyholders who may have been affected by the alleged practices highlighted in the Spitzer investigation may wish to consider taking the following action:
  • Determine whether any of the insurance brokers who have been subject to investigation have been involved in the company’s placement of insurance coverage at any time from the 1990s (as the practice of accepting contingent commissions based on the volume of business a broker was directing to the insurer took root in the 1990s) through to the present.
  • Collect and preserve information relating to insurance placement involving any of the insurance brokers and insurers under investigation, particularly with respect to “bids” solicited from purportedly competing insurance carriers.
  • Ask for copies of insurer communication on competitive proposals.
  • Collect and preserve marketing materials provided by any of the insurance brokers under investigation.
  • Collect and preserve information relating to retention of any of the insurance brokers under investigation, the scope of services to be provided, and the manner of compensation.
  • Collect and preserve information relating to the amount of commissions, fees, or other remuneration paid to any of the insurance brokers under investigation.
  • Identify and carefully review any significant claims that were resolved with any of the insurers under investigation through the involvement of any of the insurance brokers under investigation.
  • Exercise caution in any outside communications regarding the circumstances surrounding potential claims, particularly communications with the brokers and insurance companies under investigation.
For companies with an insurance or risk management department, this department may be the first point of contact and best source of information when analysing potential claims. Companies should promptly evaluate their potential claims to best protect their ability to secure independent representation and, if appropriate, to assert individual causes of action to preserve a full measure of recovery.

Going forward

There are a number of practical steps that corporate policyholders may wish to consider taking:
  • Carefully review existing insurance programmes.
  • Be actively involved in insurance placements.
  • Require a meeting with the broker for assurances that procedures are in place to ensure pricing transparency.
  • Require written confirmation of competition from brokers.
  • Require that all insurance premiums be quoted net of commissions.
  • Require a statement of all sums being earned by the broker by reason of the placements, including (but not limited to) direct, indirect, volume, and reinsurance commissions.
  • Require that their broker’s practices are consistent with legal requirements.
  • Request the broker’s ethics statement.
  • Enquire about the processes and procedures in place to ensure that transactions are completed in a legal and ethical manner, including what measures are taken when unethical behaviour is identified.
  • Seek the advice of an independent risk-management consultant to assess the broker’s performance.
  • Use the services of a number of different brokers.
  • Maintain direct relationships with underwriters.
  • Carefully consider the appropriate role of the broker, or other insurance intermediary, in the presentation of claims and negotiation of settlements.
  • Take full advantage of potential increased negotiating power during renewals.
  • Keep up to date with developments around the world.
Many hope that the recent scrutiny and publicity concerning broker remuneration will usher in a new era of greater transparency and better communications between brokers, especially large brokers, and insured companies. Certainly, as brokers disclose more information about the fees and commissions that they collect for their various services, clients will be in a better position to judge the value of those services and compare the cost of obtaining services from their brokers against other options.
End of Document
Resource ID 2-200-4590
© 2024 Thomson Reuters. All rights reserved.
Law stated as at 07-Mar-2005
Resource Type Articles
Jurisdictions
  • England
  • UK
  • United States
Related Content